NJ State Employees Deferred Compensation Plan’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,333	Closed	-$16K	–	541
2018 Q4	$16K	Hold	5,333	–	–	﹤0.01%	514
2018 Q3	$36K	Hold	5,333	–	–	0.01%	513
2018 Q2	$40K	Hold	5,333	–	–	0.01%	498
2018 Q1	$186K	Hold	5,333	–	–	0.03%	453
2017 Q4	$227K	Hold	5,333	–	–	0.04%	441
2017 Q3	$229K	Sell	5,333 -1,334	-20%	-$50K	0.04%	424
2017 Q2	$247K	Hold	6,667	–	–	0.05%	372
2017 Q1	$361K	Hold	6,667	–	–	0.07%	308
2016 Q4	$354K	Hold	6,667	–	–	0.07%	301
2016 Q3	$404K	Hold	6,667	–	–	0.08%	284
2016 Q2	$439K	Hold	6,667	–	–	0.09%	281
2016 Q1	$489K	Hold	6,667	–	–	0.1%	269
2015 Q4	$1.57M	Hold	6,667	–	–	0.32%	91
2015 Q3	$1.05M	Hold	6,667	–	–	0.23%	149
2015 Q2	$2.52M	Hold	6,667	–	–	0.49%	47
2015 Q1	$2.79M	Hold	6,667	–	–	0.54%	41
2014 Q4	$1.82M	Hold	6,667	–	–	0.36%	71
2014 Q3	$1.3M	Hold	6,667	–	–	0.26%	111
2014 Q2	$1.63M	Hold	6,667	–	–	0.32%	83
2014 Q1	$1.77M	Hold	6,667	–	–	0.36%	66
2013 Q4	$2.42M	Hold	6,667	–	–	0.49%	39
2013 Q3	$3.54M	Hold	6,667	–	–	0.77%	16
2013 Q2	$1.56M	Buy	+6,667	New	+$1.31M	0.36%	72